Bionor Immuno / news
28 Jan 2009 ... Bionor Immuno currently is recruiting volunteers in the U.S. and in Europe to participate in a Phase IIB clinical trial for its lead HIV ...
http://www.bionorimmuno.com/news2009_Bachem.html...
|
Bionor Immuno Release: Researchers Find That Vacc-4x Therapeutic ...
21 Oct 2009 ... An immunological analysis of a Phase II clinical trial demonstrated that ... Bionor Immuno is in the process of initiating a new Vacc-4x ...
http://www.biospace.com/news_story.aspx?NewsEntityId=159998...
|
Bionor Immuno / news
Bionor Immuno have started a Vacc-4x Phase IIB TOC study in US and Europe ... Vacc-4x has been tested in two clinical trials exposing the vaccine to 11 and
...
http://www.bionorimmuno.com/news2008_phaseIIB.html...
|
Bionor Immuno Welcomes Renowned Virologist Robert Redfield, MD...
Bionor Immuno announced today at the AIDS Vaccine 2009 conference in Paris, France, ... he believes carefully monitored clinical trials of therapeutic and
...
http://www.biospace.com/news_story.aspx?NewsEntityId=159592...
|
DEVELOPMENT PIPELINE THERAPEUTIC FOCUS Bionor Immuno AS is
BIONOR IMMUNO IS PRESENTING... Bionor Immuno is an active presenter at different events. QUICKLINKS ... Start of a phase IIB clinical trial ...
http://www.bionorimmuno.com/index.swf...
|
Bionor Immuno Advances HIV Peptide-Based Therapeutic Immunization ...
5 Aug 2008 ... MEXICO CITY--(BUSINESS WIRE)--Bionor Immuno today announced that it has ... 2b clinical trial of the company's lead candidate (Vacc-4x). ...
http://www.biospace.com/news_story.aspx?NewsEntityId=105768...
|
Bionor Immuno / news
Bionor Immuno has developed a therapeutic HIV vaccine that looks like it can ... So far, two clinical trials have been carried out at Ullevål University ...
http://www.bionorimmuno.com/stories.html...
|
BioSpace - Bionor Immuno News, Search Jobs, Events
Bionor Immuno Release: Researchers Find That Vacc-4x Therapeutic Peptide-Based HIV ... MD to Its Clinical Advisory Board 10/19/2009 10:45:34 AM More. ... with
Start of a Phase IIb Trial in U.S. and Europe 8/5/2008 9:17:06 AM More. ...
http://www.biospace.com/company_profile.aspx?CompanyId=10064...
|
Multiple antigen concentrations in delayed-type hypersensitivity ...
Bionor Immuno AS, P.O. Box. 1823, NO-3703 Skien, ... In a phase II clinical trial on HIV-infected patients (n = 38) of the peptide-based HIV-1 immunotherapy
...
http://www.ncbi.nlm.nih.gov/pubmed/16289707...
|
AFP: South Africa tests first African-made AIDS vaccine
22 Jul 2009 ... David Sheon, spokesman for Norwegian drug company Bionor Immuno, ... About 30 other clinical vaccine trials are underway around the world, ...
http://www.google.com/hostednews/afp/article/ALeqM5gRLpUZbbM...
|
